References
Australian Bureau of Statistics (ABS). 2015. Causes of Death, Australia, 2013. ABS cat. no. 3303.0. Canberra: ABS.
ABS. 2020a. Provisional Mortality Statistics – October 2020 release. Viewed 1 February, 2020.
ABS. 2020b. Guidance for Certifying Deaths due to COVID-19. Viewed 1 February, 2021.
ABS. 2020c. Causes of Death, Australia: Doctor Certified Deaths, Summary Tables. Viewed 16 February, 2021.
ABS. 2020d. Measuring excess mortality in Australia during the COVID-19 pandemic. Viewed 1 February, 2021.
ABS. 2020e. Causes of Death, Australia, 2019. Viewed 4 March, 2020.
ABS. 2021. Measuring excess mortality in Victoria during the COVID-19 pandemic. Viewed 11 March, 2021.
Alzheimer’s Society (Alzheimer’s UK). 2020. Office of National Statistics figures show dementia is main underlying condition for COVID-19 deaths. Viewed 1 February, 2020.
Australian Government Department of Health (Department of Health). 2020. COVID-19 outbreaks in Australian residential aged care facilities – 18 December Report.
Department of Health. 2021. Coronavirus (COVID-19) current situation and case numbers. Viewed 21 January 2021.
Australian Institute of Health and Welfare (AIHW). 2012. Multiple causes of death in Australia: an analysis of all natural and selected chronic disease causes of death 1997-2007. Cat. no. AUS 159. Canberra: AIHW.
AIHW 2020a. Dementia. Canberra: AIHW. Viewed 27 January 2021.
AIHW 2020b. Patterns of health service use by people with dementia in their last year of life: New South Wales and Victoria. Cat. no. AGE 102. Canberra: AIHW.
Beard, F., Hendry, A., & Macartney, K. 2021. Influenza vaccination uptake in Australia in 2020: impact of the COVID-19 pandemic? Communicable Diseases Intelligence (2018). 45. https://dio.org/10.33321/cdi.2021.45.10
Bianchetti, A., Rozzini, R., Guerini, F., Boffelli, S., Ranieri, P., Minelli, G., et al. 2020. Clinical Presentation of COVID19 in Dementia Patients. The journal of nutrition, health & aging, 24(6), 560–562. https://doi.org/10.1007/s12603-020-1389-1
Buckley, R., Waller, M., Masters, C.L., & Dobson, A. 2019. To what extent does age at death account for sex differences in Alzheimer’s disease mortality rates? American Journal of Epidemiology. 2019; 188(7), pp.1213–1223.
FluTracking Australia. 2020. Weekly Interim Report: Australia, Week ending 27 December 2020. Viewed 21 January 2021.
Gao, L., Calloway, R., Zhao, E., Brayne, C., Matthews, F.E., & Medical Research Council Cognitive Function and Ageing Collaboration. 2018. Accuracy of death certification of dementia in population-based samples of older people: analysis over time. Age and ageing. 47(4), 589-594.
Kennedy, M., Helfand, B.K.I., Gou, R.Y., Gartaganis, S.L., Webb, M., Moccia, J.M., et al. 2020. Delirium in Older Patients With COVID-19 Presenting to the Emergency Department. JAMA Network Open, 3(11):e2029540. doi:10.1001/jamanetworkopen.2020.29540
Kung, S., Doppen, M., Black, M., Hills, T., & Kearns, N. 2021. Reduced mortality in New Zealand during the COVID-19 pandemic. The Lancet, 397(10268), p.25.
Kuo, C.L., Pilling, L.C., Atkins, J.L., Masoli, J.A., Delgado, J., Kuchel, G.A., et al. 2020a. ApoE e4e4 genotype and mortality with COVID-19 in UK Biobank. The Journals of Gerontology: Series A, 75(9), pp.1801-1803.
Kuo, C. L., Pilling, L. C., Atkins, J. L., Masoli, J. A., Delgado, J., Kuchel, G. A., & Melzer, D. 2020b. APOE e4 genotype predicts severe COVID-19 in the UK Biobank community cohort. The Journals of Gerontology: Series A, 75(11), 2231-2232.
Morgan, D., Ino, J., Di Paolantonio, G., & Murtin, F. 2020. OECD Health Working Paper No. 122: Excess mortality: Measuring the direct and indirect impact of COVID-19. https://dx.doi.org/10.1787/c5dc0c50-en.
Numbers, K. & Brodaty, H. 2021. The effects of the COVID-19 pandemic on people with dementia. Nature Review Neurology, 17, pp.69–70.
Parliament of Australia. 2020. COVID-19 and aged care: a quick guide. Viewed 21 January 2021.
Pearce, C., McLeod, A., Gardner, K., Supple, J., Epstein, D., & Buttery, J. 2020. THE GP Insights Series no 7: Primary Care and SARS-CoV-2: The first 40 weeks of the pandemic year. www.polargp.org.au.
Poloni, T.E., Carlos, A.F., Cairati, M., Cutaia, C., Medici, V., Marelli, E., et al. 2020. Prevalence and prognostic value of Delirium as the initial presentation of COVID-19 in the elderly with dementia: An Italian retrospective study. EClinicalMedicine, 26, 100490.
Rao, C. 2020. Medical certification of cause of death for COVID-19. Bulletin of the World Health Organization, 98(5), 298.
Royal Commission into Aged Care Quality and Safety (Royal Commission) 2020. Aged care and COVID-19: a special report. Canberra: Royal Commission.
Suárez-González, A., Livingston, G., Fay Low, L., Cahill, S., Hennelly, N., Dawson, W.D., et al. 2020. Impact and mortality of COVID-19 on people living with dementia: cross-country report.
Sutherland, K., Chessman, J., Zhao, J., Sara, G., Shetty, A., Smith, S., et al. 2020. Impact of COVID-19 on healthcare activity in NSW, Australia. Public Health Research & Practice, 30(4).
Waller, M., Mishra, G., & Dobson, A. 2017. Estimating the prevalence of dementia using multiple linked administrative health records and capture-recapture methodology. Emerging Themes in Epidemiology 14:3.
Wang, H., Li, T., Barbarino, P., Gauthier, S., Brodaty, H., Molinuevo, J.L., et al. 2020. Dementia care during COVID-19. The Lancet, 395(10231), pp.1190-1191.
Yang, H., Liang, X., Hou, H., Xu, J., Shi, L., & Wang, Y. 2021. The association of dementia with COVID-19 mortality: Evidence based on adjusted effect estimates. Journal of Infection. 2021 (Epub ahead of print). doi: 10.1016/j.jinf.2021.02.013.